Advanced Filters
noise

a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Found 10,489 clinical trials
C Cui chuanliang, doctor

A Study of ST-1898 for Unresectable or Metastatic Melanoma

ST-1898 is a receptor tyrosine kinase (RTK) inhibitor for multi-targets, especially for VEGFR2, c-MET, AXL, PDGFRA, RET, KIT etc. This trial is to evaluate its safety, tolerability, pharmacokinetic, and efficacy in subjects with unresectable or metastatic melanoma. In phase Ib, the primary objectives are to assess the safety and tolerability, …

18 years of age All Phase 1/2

A Phase 1 Study of FZ008-145 in Healthy Subjects.

The study will be conducted in 5 parts: Part A (single ascending dose [SAD] in solution formulation), Part B (SAD in tablet formulation), Part C (food effect [FE]), Part D (cold pressor test [CPT] to evaluate pain tolerance following single dose), and Part E (multiple ascending dose [MAD] in tablet …

18 - 65 years of age All Phase 1
E E. (Jort) G.B. Vijverberg, Professor, MD, PhD

A Study to Assess THN391 in Subjects With Alzheimer's Disease

This is a Phase 1b study to evaluate different doses of the drug and see whether a drug is safe and how it behaves in the body. THN391 has already been assessed in healthy people without Alzheimer's disease. This is the first study of THN391 in patients with Early Alzheimer's …

65 - 85 years of age All Phase 1

"Using a Multisite TENS SysteM to Improve Fibromyalgia-related Symptoms.

Fibromyalgia is a debilitating pain condition that is characterized by the chronic occurrence of pain affecting the musculoskeletal system, a sensitivity to pressure stimuli, and a low threshold to noxious stimuli. The topography of pain is widespread, although it could be more pronounced in some bodily regions. Besides pain, patients …

18 - 75 years of age All Phase N/A
J Juan C. Pedemonte, MD

Development of a Pharmacodynamic Model for Propofol in Older Adults

The goal of this pharmacodynamic study is to develop a model for Propofol administration for older adults (>65 years). The main objective is to create a model based on a new pharmacodynamic parameter, derived from frontal electroencephalogram (EEG), to admininster Propofol in older adults. With this new model, the investigators …

65 - 99 years of age All Phase N/A
L Li Zhang, professor

A Study of AK146D1 for Injection in Advanced Solid Tumors

This is an first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK146D1 for injection in advanced solid tumors.

18 - 75 years of age All Phase 1
K Kira McNamee, BA

Virtual Reality Exposure for Vaginismus: A Replicated Single-Case Design

Vaginismus is a sexual dysfunction characterized by involuntary tightening of the pelvic floor muscles, preventing vaginal intercourse. It is defined by an intense fear of vaginal penetration, leading to persistent difficulties with vaginal intercourse and gynaecological exams. Psychological factors play a significant role in vaginismus. If the pelvic floor muscle …

19 years of age Female Phase N/A

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

This study is a multicenter Phase Ib/II clinical trial aimed at evaluating the safety, tolerability and efficacy of SCTB35 in patients with systemic lupus erythematosus (SLE).

18 - 75 years of age All Phase 1/2

A Study of FB1003 in Healthy and Osteoarthritis Pain Subjects

The purpose of Part 1 is to evaluate safety and tolerability of FB1003 when given subcutaneously to healthy participants. Blood tests will be done to examine blood exposure, concentration and half-life of FB1003 following administrations. For each participant, the study will last up to about 12 weeks for single ascending …

18 - 75 years of age All Phase 1

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

The Long-Covid (LC)-Revitalize clinical study is testing repurposed drug treatments for Long Covid, involving adult participants from Brazil, Canada, Italy, Uganda, the United States, and Zambia. To qualify, participants must have had Covid-19 and experienced Long Covid symptoms for at least three months. The main goal of the study is …

18 - 65 years of age All Phase 3

Simplify language using AI